Literature DB >> 11341833

Short, strong hydrogen bonds at the active site of human acetylcholinesterase: proton NMR studies.

M A Massiah1, C Viragh, P M Reddy, I M Kovach, J Johnson, T L Rosenberry, A S Mildvan.   

Abstract

Cholinesterases use a Glu-His-Ser catalytic triad to enhance the nucleophilicity of the catalytic serine. We have previously shown by proton NMR that horse serum butyryl cholinesterase, like serine proteases, forms a short, strong hydrogen bond (SSHB) between the Glu-His pair upon binding mechanism-based inhibitors, which form tetrahedral adducts, analogous to the tetrahedral intermediates in catalysis [Viragh, C., et al. (2000) Biochemistry 39, 16200-16205]. We now extend these studies to human acetylcholinesterase, a 136 kDa homodimer. The free enzyme at pH 7.5 shows a proton resonance at 14.4 ppm assigned to an imidazole NH of the active-site histidine, but no deshielded proton resonances between 15 and 21 ppm. Addition of a 3-fold excess of the mechanism-based inhibitor m-(N,N,N-trimethylammonio)trifluoroacetophenone (TMTFA) induced the complete loss of the 14.4 ppm signal and the appearance of a broad, deshielded resonance of equal intensity with a chemical shift delta of 17.8 ppm and a D/H fractionation factor phi of 0.76 +/- 0.10, consistent with a SSHB between Glu and His of the catalytic triad. From an empirical correlation of delta with hydrogen bond lengths in small crystalline compounds, the length of this SSHB is 2.62 +/- 0.02 A, in agreement with the length of 2.63 +/- 0.03 A, independently obtained from phi. Upon addition of a 3-fold excess of the mechanism-based inhibitor 4-nitrophenyl diethyl phosphate (paraoxon) to the free enzyme at pH 7.5, and subsequent deethylation, two deshielded resonances of unequal intensity appeared at 16.6 and 15.5 ppm, consistent with SSHBs with lengths of 2.63 +/- 0.02 and 2.65 +/- 0.02 A, respectively, suggesting conformational heterogeneity of the active-site histidine as a hydrogen bond donor to either Glu-327 of the catalytic triad or to Glu-199, also in the active site. Conformational heterogeneity was confirmed with the methylphosphonate ester anion adduct of the active-site serine, which showed two deshielded resonances of equal intensity at 16.5 and 15.8 ppm with phi values of 0.47 +/- 0.10 and 0.49 +/- 0.10 corresponding to average hydrogen bond lengths of 2.59 +/- 0.04 and 2.61 +/- 0.04 A, respectively. Similarly, lowering the pH of the free enzyme to 5.1 to protonate the active-site histidine (pK(a) = 6.0 +/- 0.4) resulted in the appearance of two deshielded resonances, at 17.7 and 16.4 ppm, consistent with SSHBs with lengths of 2.62 +/- 0.02 and 2.63 +/- 0.02 A, respectively. The NMR-derived distances agree with those found in the X-ray structures of the homologous acetylcholinesterase from Torpedo californica complexed with TMTFA (2.66 +/- 0.28 A) and sarin (2.53 +/- 0.26 A) and at low pH (2.52 +/- 0.25 A). However, the order of magnitude greater precision of the NMR-derived distances establishes the presence of SSHBs at the active site of acetylcholinesterase, and detect conformational heterogeneity of the active-site histidine. We suggest that the high catalytic power of cholinesterases results in part from the formation of a SSHB between Glu and His of the catalytic triad.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11341833     DOI: 10.1021/bi010243j

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  14 in total

1.  Specific protein dynamics near the solvent glass transition assayed by radiation-induced structural changes.

Authors:  M Weik; R B Ravelli; I Silman; J L Sussman; P Gros; J Kroon
Journal:  Protein Sci       Date:  2001-10       Impact factor: 6.725

2.  Deuterium solvent isotope effect and proton-inventory studies of factor Xa-catalyzed reactions.

Authors:  Daoning Zhang; Ildiko M Kovach
Journal:  Biochemistry       Date:  2006-11-28       Impact factor: 3.162

3.  Molecular dynamics simulation and conformational analysis of some catalytically active peptides.

Authors:  Bahareh Honarparvar; Adam A Skelton
Journal:  J Mol Model       Date:  2015-04-01       Impact factor: 1.810

4.  Investigation of the catalytic triad of arylamine N-acetyltransferases: essential residues required for acetyl transfer to arylamines.

Authors:  James Sandy; Adeel Mushtaq; Simon J Holton; Pamela Schartau; Martin E M Noble; Edith Sim
Journal:  Biochem J       Date:  2005-08-15       Impact factor: 3.857

5.  Accumulation of tetrahedral intermediates in cholinesterase catalysis: a secondary isotope effect study.

Authors:  Jose R Tormos; Kenneth L Wiley; Yi Wang; Didier Fournier; Patrick Masson; Florian Nachon; Daniel M Quinn
Journal:  J Am Chem Soc       Date:  2010-11-24       Impact factor: 15.419

6.  Catalytic reaction mechanism of acetylcholinesterase determined by Born-Oppenheimer ab initio QM/MM molecular dynamics simulations.

Authors:  Yanzi Zhou; Shenglong Wang; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2010-07-08       Impact factor: 2.991

7.  Proton bridging in the interactions of thrombin with small inhibitors.

Authors:  Ildiko M Kovach; Paul Kelley; Carol Eddy; Frank Jordan; Ahmet Baykal
Journal:  Biochemistry       Date:  2009-08-04       Impact factor: 3.162

8.  Aging mechanism of soman inhibited acetylcholinesterase.

Authors:  Gulseher Sarah Sirin; Yanzi Zhou; Lee Lior-Hoffmann; Shenglong Wang; Yingkai Zhang
Journal:  J Phys Chem B       Date:  2012-09-28       Impact factor: 2.991

9.  Structure-based design and synthesis of N(omega)-nitro-L-arginine-containing peptidomimetics as selective inhibitors of neuronal nitric oxide synthase. Displacement of the heme structural water.

Authors:  Jiwon Seo; Jotato Igarashi; Huiying Li; Pavel Martasek; Linda J Roman; Thomas L Poulos; Richard B Silverman
Journal:  J Med Chem       Date:  2007-04-11       Impact factor: 7.446

10.  Proton bridging in the interactions of thrombin with hirudin and its mimics.

Authors:  Ildiko M Kovach; Lazaros Kakalis; Frank Jordan; Daoning Zhang
Journal:  Biochemistry       Date:  2013-04-01       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.